New Zealand markets close in 5 hours 53 minutes

Ryman Healthcare Limited (RYM.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
4.4600-0.0400 (-0.89%)
As of 10:44AM NZST. Market open.
Currency in NZD

Valuation measures4

Market cap (intra-day) 3.09B
Enterprise value 5.58B
Trailing P/E 11.13
Forward P/E 20.70
PEG ratio (5-yr expected) 2.29
Price/sales (ttm)4.41
Price/book (mrq)0.64
Enterprise value/revenue 9.19
Enterprise value/EBITDA 14.31

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-16.67%
S&P500 52-week change 323.42%
52-week high 36.9900
52-week low 34.3400
50-day moving average 34.7812
200-day moving average 35.7663

Share statistics

Avg vol (3-month) 3896.55k
Avg vol (10-day) 3974.91k
Shares outstanding 5687.64M
Implied shares outstanding 6687.64M
Float 8653.84M
% held by insiders 112.53%
% held by institutions 126.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.21
Forward annual dividend yield 43.95%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.05
Payout ratio 420.52%
Dividend date 3N/A
Ex-dividend date 408 Dec 2022
Last split factor 25:1
Last split date 326 Jan 2007

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 40.63%
Operating margin (ttm)0.82%

Management effectiveness

Return on assets (ttm)0.03%
Return on equity (ttm)5.90%

Income statement

Revenue (ttm)616.65M
Revenue per share (ttm)1.01
Quarterly revenue growth (yoy)17.50%
Gross profit (ttm)N/A
EBITDA 40.3M
Net income avi to common (ttm)250.54M
Diluted EPS (ttm)0.4000
Quarterly earnings growth (yoy)-3.80%

Balance sheet

Total cash (mrq)33.3M
Total cash per share (mrq)0.05
Total debt (mrq)2.52B
Total debt/equity (mrq)51.83%
Current ratio (mrq)1.56
Book value per share (mrq)7.07

Cash flow statement

Operating cash flow (ttm)745.07M
Levered free cash flow (ttm)-110.35M